Acute promyelocytic leukemia (APL), with specific features in cell morphology, is classified as M3 by French-American-British (FAB).Among M3, 95% of patients s
Research Objective andOverviewrnIt is necessary to find effective Chinese materia medica (CMM)for the treatment of refractory hematopathy as commonly used pred